| VAGUE | | Protox Therapeutics | PRX-T | 0.840 | A drug that corrects complications that occur with the prostrate and prostrate cancer. Entering phase 2 clinical trials, has large market opportunities. Have done safety studies. In good shape regarding their cash position. | 2008-03-26 | |
| BUY | | Zoomed | ZMD-X | 0.370 | Has raised capital. Produces a hand held company to assist primary care physicians, to help electronic prescribing. It doesn’t cost the physician anything. The company is doing very well. | 2008-03-26 | |
| BUY | | Covalon Technologies | COV-X | 2.640 | Has done tremendously well. They focus on wound care products, and coatings for products. The company has tremendous potential, they signed a deal with a large British company. Great opportunity, going to do well going forward. | 2008-03-26 | |
| BUY | | Bioniche Life Sciences | BNC-T | 0.920 | A very interesting company. Has an animal health product, human health products focused on bladder cancer and a vaccine for cattle. Likes the company, has existing products (short-term revenue stream) and has future opportunity and a potential blockbuster product. A significant opportunity. | 2008-03-26 | |
| WEAK BUY | | Microbix Biosystems | MBX-T | 0.760 | Been around for a long time. Has a broad range of technologies. Have recently signed licensed for Virusmax, which can double the yield of virus production for vaccinations. Bull semen-sexing technology. Have some very interesting technologies. Watching it very closely. Like the company. | 2008-03-26 | |
| TOP PICK | | Healthscreen Solutions Inc. | MDU-X | 0.295 | Focuses on providing software for doctors, directed at Primary physicians. Have lots of new products coming through. Great opportunity. | 2008-03-26 | |
| TOP PICK | | YM BioSciences | YM-T | 0.990 | Recently suffered when phase 3 testing failed. Has cash in the bank, has a long runway (cash on a burn rate). Have 2 products in phase 3, one of which is approved in India and China. Great opportunities. Way undervalued. | 2008-03-26 | |
Rss Feed